Retatrutide
FeaturedA triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
Beta-MSH is a melanocortin peptide processed from pro-opiomelanocortin, involved in regulating pigmentation, energy homeostasis, and inflammation. Researchers study its role in appetite regulation and energy balance.
In the literature, Beta-MSH appears most often in work focused on appetite control, metabolism and inflammation. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Beta-MSH is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
An NNMT inhibitor studied for increasing cellular metabolism, reducing fat mass, and preserving muscle during weight loss research.
An AMPK activator studied as an exercise mimetic for endurance and metabolic research.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.